Sintx Technologies (SINT) Operating Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 3.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39% |
| Dec 31, 2025 | 60.85% |
| Sep 30, 2025 | -6.30% |
| Jun 30, 2025 | 1.43% |
| Mar 31, 2025 | 6.12% |
| Dec 31, 2024 | 12.56% |
| Sep 30, 2024 | -31.39% |
| Jun 30, 2024 | -4.67% |
| Mar 31, 2024 | -4.01% |
| Dec 31, 2023 | -6.76% |
| Sep 30, 2023 | -14.18% |
| Jun 30, 2023 | -20.41% |
| Mar 31, 2023 | -24.26% |
| Dec 31, 2022 | -20.64% |
| Sep 30, 2022 | -18.00% |
| Jun 30, 2022 | -22.28% |
| Mar 31, 2022 | -18.52% |
| Dec 31, 2021 | -31.39% |
| Sep 30, 2021 | 27.34% |
| Jun 30, 2021 | -7.50% |
| Mar 31, 2021 | -8.39% |
| Dec 31, 2020 | -43.76% |
| Sep 30, 2020 | -7.14% |
| Jun 30, 2020 | -4.79% |
| Mar 31, 2020 | -0.95% |
| Dec 31, 2019 | 21.12% |
| Sep 30, 2019 | 19.07% |
| Jun 30, 2019 | 15.26% |
| Mar 31, 2019 | 11.36% |
| Dec 31, 2018 | 78.28% |
| Sep 30, 2018 | -37.94% |
| Jun 30, 2018 | 9.85% |
| Mar 31, 2018 | 17.73% |
| Dec 31, 2017 | 37.49% |
| Sep 30, 2017 | 29.51% |
| Jun 30, 2017 | 45.46% |
| Mar 31, 2017 | 23.70% |
| Dec 31, 2016 | -5.22% |
| Sep 30, 2016 | -16.70% |
| Jun 30, 2016 | 2.20% |
| Mar 31, 2016 | 3.60% |